Should the rat mirror the situation in the mouse, it would signify that either Dnd1 target genes differ between females and males or that the downregulation of some cell cycle inhibitors might be a secondary effect and not the primary cause of tumor development. The gene discussed is DND1; the disease is neoplasm.